EPICORE BIOSYSTEMS, INC.
CAMBRIDGE, MA · Founded 2017 · CIK 0001755876 · Medtech · Private
Skin-interfaced wearable microfluidic device with smartphone image processing for real-time sweat analysis and chloride measurement
- Grants
- $552K
- 2 awards
- Sector median: 1
- Raised
- $32M
- 4 Form D · Jan 2025
- 21 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 9
- 4 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $350,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Soft, Epidermal Biosystems with Advanced Sensing and Microfluidics Capabilities for Assessing Fatigability Biomarkers | $251,695 | |
| Private capital raised | Form D · SEC | $4,650,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Wearable Microfluidic Systems for Measuring Sweat Biomarkers in Cystic Fibrosis Patients During Exercise in Remote Settings | $299,936 | |
| Private capital raised | Form D · SEC | $1,539,999 | |
| Private capital raised | Form D · SEC | $25,686,104 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1216 | PIRAEUS MEDICAL, INC. | — | $14M |
| 1217 | Angel Eye Camera Systems, LLC | — | $626K |
| 1218 | Cerillo, Inc | — | $3.8M |
| 1219 | EPICORE BIOSYSTEMS, INC. | — | $32M |
| 1220 | MICROTRANSPONDER, INC. | — | $108M |
| 1221 | TF Instruments | — | — |
| 1222 | Fresenius Medical Care Cedar Hill, LLC | — | $928K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Alexander AranyosiExecutive Officer
- Roozbeh GhaffariDirector · Executive Officer
- ROOZBEH GHAFFARIDirector · Executive Officer
- Laura LangDirector
- LAURA LANGDirector
- Stephen LeeExecutive Officer
- STEPHEN LEEExecutive Officer
- Weihua LiExecutive Officer
- Jeffrey ModelExecutive Officer
- JEFF MODELExecutive Officer
- Kimberly QuerreyDirector
- John RogersDirector · Executive Officer
- JOHN ROGERSDirector
- James RyanExecutive Officer
- JAMES RYANExecutive Officer
- John WrightExecutive Officer
- JOHN WRIGHTExecutive Officer
Patents
- Biofluid Computation Measurement System With Re-usable Skin Facing Electrodesapplication
- Wearable Biofluid Volume And Composition Measurement Systemgranted
- Wearable Fluidic Device And System For Sweat Collection And Extractionapplication
- Eab Sensing Devices With Biofluid Sample Concentrationgranted
- Wearable Fluidic System For Measuring Sweat Compositiongranted
- Wearable Fluidic Device And System For Sweat Collection And Extractiongranted
- Wearable Fluidic Device And System With Integrated Electronicsapplication
- Wearable Fluidic Device And System For Sweat Collection And Extractionapplication
- Wearable Fluidic System For Measuring Sweat Compositionapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.